2- (p- chlorophenyl)- 4- (4- N- ethylamidepiperazinyl)quinoline
structure in first source
Also Known As:
Ro 23-1590; Ro23-1590
Networked: 1
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
1. | Hypothermia
01/01/1996
- " Ro23-1590 had no effect on anxiolysis and hypothermia, but was an agonist at other tests. " 01/01/1996
- " Putative partial agonists Ro16-6028, Ro23-1590, Ro23-0364, and abecarnil were compared with U78875, a mixed agonist-antagonist, and CGS8216, an inverse agonist, in five BDZR-mediated functions: hyperphagia, anxiolysis, sedation, hypothermia, and anticonvulsant activity. "
|
2. | Hyperphagia (Overeating)
01/01/1996
- " Putative partial agonists Ro16-6028, Ro23-1590, Ro23-0364, and abecarnil were compared with U78875, a mixed agonist-antagonist, and CGS8216, an inverse agonist, in five BDZR-mediated functions: hyperphagia, anxiolysis, sedation, hypothermia, and anticonvulsant activity. "
|
|
Related Drugs and Biologics